Govt caps trade margins on 137 anti-cancer drugs at 30 pc of MRP
New Delhi, Oct 18 (IANS) The National Pharmaceutical Pricing Authority (NPPA) has capped trade margins on 137 non-scheduled anti-cancer drugs at 30 per cent of the maximum retail price (MRP), a move expected to reduce prices of several cancer medicines by up to 70 per cent and improve affordability for patients, according to an official statement.